This site is intended for healthcare professionals residing in Canada.

Visit Pfizer AcademySearch

Menu

Close

Sign InLog Out
  • EN
ProductsTherapy AreasExplore ContentExplore
ContentGo to Explore ContentEventsMaterialsVideosPatient SupportContact
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Français

Menu

Close

Home

Recommendations

SOGC Recommendations

NACI Recommendations

CIQ Recommendations

About RSV

About RSV

Infants at Risk

Individuals ≥ 60 Years of Age

About ABRYSVO

Reconstitution and Storage

Dosing and Administration

Mechanism of Action

Efficacy and Safety Profiles

Clinical Trials

MATISSE Study Design

MATISSE Data

MATISSE Safety Profile

RENOIR Study Design

RENOIR Data

RENOIR Safety Profile

More

Coverage Information

Patient Profiles

FAQ

Resources

Product MonographSafety Information
Pfizer Respiratory Vaccine Portfolio
Recommendations from the CIQThe CIQ recommends an RSV vaccination program using authorized vaccines for the following groups in this order of priority1
  1. Nursing home and Support Program for the Autonomy of Seniors, Intermediate Resources (RI-SAPA) residents;
  2. Retirement home residents aged ≥ 75 years;
  3. Community-based individuals with a chronic disease aged ≥ 75 years.
To see the complete statement,click here.To see the complete statement,
click here.

CIQ: Comité sur l’immunisation du Québec; RSV: respiratory syncytial virus

CIQ: Comité sur l’immunisation du Québec;
RSV: respiratory syncytial virusReference:Utilisation du vaccin contre le virus respiratoire syncytial (VRS) chez les personnes âgées de 60 ans et plus dans le programme québécois d’immunisation. Institut national de santé publique du Québec (INSPQ). May 2024.RecommendationsAbout RSV

Learn more about respiratory syncytial virus and its impact on high-risk populations.

PP-A1G-CAN-0117-EN

To report an adverse event, please call 1-866-723-7111

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign in or RegisterSign inRegisterAccountSign Out

© Pfizer Canada ULC 2024. All rights reserved. The information is intended only for healthcare professionals resident in Canada. ®Pfizer Inc., used under license.

PP-UNP-CAN-0145-EN
You are now leaving Pfizerpro.ca website
Links to other sites are provided as a convenience to the viewer, and should not be taken as an endorsement of the sites or an association with their owners. Pfizer Canada accepts no responsibility for the content of linked sites.
You are now leaving the PfizerPro Portal.
You are about to view resources made available by Pfizer Academy. 
These resources include learning programs and upcoming events. By selecting Go to link below, you acknowledge and certify that you are a Canadian Healthcare Professional.
PP-UNP-CAN-0013 EN
Are you a resident of Quebec?